Condition: Parkinson Disease · Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
* Determine clinical characteristics of parkinsonian patients in various stages of disease; * Measure peripheral neurodegeneration, synaptic, and inflammation biomarkers in a population of parkinsonian patients at various stages of disease. * Measure vesicular neurodegeneration, synaptic and inflammation biomarkers
This description comes directly from the study's public registry record.
Giulia Di Lazzaro, MD · 0630154303 · giulia.dilazzaro@policlinicogemelli.it
Flavia Torlizzi · 0630156433 · flavia.torlizzi@policlinicogemelli.it
Always discuss trial participation with your own doctor first.
| Flavia Torlizzi | Roma, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05769699